Biotricity, Inc.
BTCY
$0.25
$0.00-1.40%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.19% | 18.95% | 21.00% | 16.50% | 21.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.19% | 18.95% | 21.00% | 16.50% | 21.73% |
| Cost of Revenue | -13.89% | -12.80% | -9.71% | -20.04% | 6.22% |
| Gross Profit | 17.64% | 29.37% | 31.89% | 31.07% | 27.49% |
| SG&A Expenses | -8.17% | 2.49% | -27.90% | -29.24% | -20.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.37% | 1.05% | -16.82% | -26.75% | -10.97% |
| Operating Income | 360.89% | 188.98% | 125.24% | 71.90% | 86.82% |
| Income Before Tax | 41.66% | 55.76% | 81.81% | 53.72% | 56.23% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 41.66% | 55.76% | 81.81% | 53.72% | 56.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 41.66% | 55.76% | 81.81% | 53.72% | 56.23% |
| EBIT | 360.89% | 188.98% | 125.24% | 71.90% | 86.82% |
| EBITDA | 364.12% | 189.91% | 125.41% | 71.93% | 86.92% |
| EPS Basic | 23.53% | 60.68% | 94.15% | 83.55% | 83.96% |
| Normalized Basic EPS | 47.28% | 62.82% | 88.93% | 83.33% | 84.00% |
| EPS Diluted | 23.53% | 60.54% | 94.15% | 83.50% | 83.96% |
| Normalized Diluted EPS | 47.28% | 62.82% | 88.93% | 83.33% | 84.00% |
| Average Basic Shares Outstanding | 13.86% | 19.00% | 85.50% | 179.18% | 169.87% |
| Average Diluted Shares Outstanding | 13.86% | 19.00% | 85.50% | 179.18% | 169.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.76% | -1.29% | -1.72% | -- | -1.21% |